SAMe Benefits For Depression, Osteoarthritis, Liver Disease Noted By AHRQ
This article was originally published in The Tan Sheet
Executive Summary
Dose escalation and risk benefit studies of SAMe for treatment of depression, osteoarthritis and liver disease are among the "promising" areas of future research involving the supplement ingredient identified by the Agency for Healthcare Research & Quality